/
Other
Vaccine
36
Pipeline Programs↗
33
Active Trials↗
40
Companies Involved↗
Vaccine is a moderately active landscape with 36 programs across 40 companies. The most active players are Sanofi, Moderna, Pfizer. 12 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 111
Phase 27
Approved
No programs
Analysis
Modality Breakdown
72%
Vaccine
13 of 18 classified programs — the dominant modality here.
Vaccine leads; the ring shows all 18 classified programs, each share of the total. Modality classified for 100% of 36 pipeline programs.
Analysis
Trial Status
514
clinical trials
Completed406 · 79%
Unknown status40 · 8%
Terminated22 · 4%
Recruiting15 · 3%
Active, not recruiting14 · 3%
Withdrawn12 · 2%
Other5 · 1%
Clinical Trials
Trial Activity
514 trials
Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya
Recruiting·—·Phase 4·NCT07487077·1,071 enrolled
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Recruiting·—·Phase 2·NCT07199569·744 enrolled
Page 1 of 35
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)